-+ 0.00%
-+ 0.00%
-+ 0.00%

Aytu BioPharma Earnings Review: Q2 Summary

Benzinga·02/03/2026 21:51:06
Listen to the news

The earnings results for Aytu BioPharma (NASDAQ:AYTU) for Q2 were made public on Tuesday, February 3, 2026 at 04:05 PM.

Here's a comprehensive overview of the announcement.

Earnings

Aytu BioPharma missed estimated earnings by -162.0%, reporting an EPS of $-1.05 versus an estimate of $-0.4.

Revenue was down $1.06 million from the same period last year.

Historical Earnings Summary

In the previous quarter, the company beat on EPS by $0.06, resulting in a 1.0% increase change in the share price the following day.

Here's a look at Aytu BioPharma's past performance:

Quarter Q1 2026 Q4 2025 Q3 2025 Q2 2025
EPS Estimate -0.14 -0.04 -0.17 0
EPS Actual -0.08 -0.25 0.21 -0.28
Revenue Estimate 12.61M 17.98M 13.74M 15.55M
Revenue Actual 13.90M 15.13M 18.45M 16.22M

To track all earnings releases for Aytu BioPharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.